Development of AVIPure® - AAV9: The first highly reusable AAV affinity resin with NaOH cleaning capabilities
High doses of AAV are becoming increasingly common in gene therapies. In order to meet the growing and ever-changing needs of the biopharmaceutical industry, Avitide has developed the world's first highly reusable affinity chromatography resin with sodium hydroxide (NaOH) cleaning capabilities - AVIPure® - AAV9.
Thomas Scanlon, Ph.D.
Director of Ligand Discovery